{"id":3987,"date":"2022-10-02T19:23:18","date_gmt":"2022-10-02T17:23:18","guid":{"rendered":"https:\/\/www.pharmin.sk\/?p=3987"},"modified":"2022-10-02T19:23:18","modified_gmt":"2022-10-02T17:23:18","slug":"publikovali-sme-strucna-analyza-potreby-a-dostupnosti-lokalnych-vstupnych-udajov-pre-potreby-farmako-ekonomickych-analyz-na-slovensku","status":"publish","type":"post","link":"https:\/\/www.pharmin.sk\/sk\/aktuality\/publikovali-sme-strucna-analyza-potreby-a-dostupnosti-lokalnych-vstupnych-udajov-pre-potreby-farmako-ekonomickych-analyz-na-slovensku\/","title":{"rendered":"Publikovali sme: Stru\u010dn\u00e1 anal\u00fdza potreby a dostupnosti lok\u00e1lnych vstupn\u00fdch \u00fadajov pre potreby farmako-ekonomick\u00fdch anal\u00fdz na Slovensku"},"content":{"rendered":"

So zvy\u0161uj\u00facimi sa v\u00fddavkami na lieky sa zvy\u0161uje potreba efekt\u00edvneho vynakladania verejn\u00fdch financi\u00ed. K\u013e\u00fa\u010dov\u00fdm krit\u00e9riom pri zara\u010fovan\u00ed nov\u00fdch liekov do syst\u00e9mu \u00fahrad na Slovensku je okrem klinick\u00e9ho pr\u00ednosu aj n\u00e1kladov\u00e1 efekt\u00edvnos\u0165 a dopad na verejn\u00e9 zdroje. Farmako-ekonomick\u00e9 anal\u00fdzy m\u00f4\u017eu by\u0165 objekt\u00edvnym n\u00e1strojom na posudzovanie len vtedy, ak zoh\u013ead\u0148uj\u00fa lok\u00e1lne \u00fadaje o epidemiol\u00f3gii, mana\u017emente a n\u00e1kladovosti ochorenia. Pri adapt\u00e1cii FER na slovensk\u00e9 podmienky je preto potrebn\u00e9 ma\u0165 k dispoz\u00edcii aktu\u00e1lne a metodicky korektn\u00e9 \u00fadaje, ktor\u00e9 reflektuj\u00fa vyu\u017e\u00edvanie zdravotnej starostlivosti v re\u00e1lnej klinickej praxi na Slovensku.<\/p>\n

\u010cl\u00e1nok si m\u00f4\u017eete stiahnu\u0165 TU<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

So zvy\u0161uj\u00facimi sa v\u00fddavkami na lieky sa zvy\u0161uje potreba efekt\u00edvneho vynakladania verejn\u00fdch financi\u00ed. K\u013e\u00fa\u010dov\u00fdm krit\u00e9riom pri zara\u010fovan\u00ed nov\u00fdch liekov do syst\u00e9mu \u00fahrad na Slovensku je okrem klinick\u00e9ho pr\u00ednosu aj n\u00e1kladov\u00e1 efekt\u00edvnos\u0165 a dopad na verejn\u00e9 zdroje. Farmako-ekonomick\u00e9 anal\u00fdzy m\u00f4\u017eu by\u0165 objekt\u00edvnym n\u00e1strojom na posudzovanie len vtedy, ak zoh\u013ead\u0148uj\u00fa lok\u00e1lne \u00fadaje o epidemiol\u00f3gii, mana\u017emente a n\u00e1kladovosti<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3987","post","type-post","status-publish","format-standard","hentry","category-aktuality"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/3987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/comments?post=3987"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/3987\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/media?parent=3987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/categories?post=3987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/tags?post=3987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}